Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine‐2 receptor antagonists: A 15‐year hospital cohort study using a common data model.

MLA

Seo, Seung In, et al. “Comparative Risk of Clostridium Difficile Infection between Proton Pump Inhibitors and Histamine‐2 Receptor Antagonists: A 15‐year Hospital Cohort Study Using a Common Data Model.” Journal of Gastroenterology & Hepatology, vol. 35, no. 8, Aug. 2020, pp. 1325–30. EBSCOhost, https://doi.org/10.1111/jgh.14983.

APA

Seo, S. I., You, S. C., Park, C. H., Kim, T. J., Ko, Y. S., Kim, Y., Yoo, J. J., Kim, J., & Shin, W. G. (2020). Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine‐2 receptor antagonists: A 15‐year hospital cohort study using a common data model. Journal of Gastroenterology & Hepatology, 35(8), 1325–1330. https://doi.org/10.1111/jgh.14983

Chicago

Seo, Seung In, Seng Chan You, Chan Hyuk Park, Tae Joon Kim, You Sang Ko, Yerim Kim, Jong Jin Yoo, Jinseob Kim, and Woon Geon Shin. 2020. “Comparative Risk of Clostridium Difficile Infection between Proton Pump Inhibitors and Histamine‐2 Receptor Antagonists: A 15‐year Hospital Cohort Study Using a Common Data Model.” Journal of Gastroenterology & Hepatology 35 (8): 1325–30. doi:10.1111/jgh.14983.